Organon & Co. (OGN)
NYSE: OGN · IEX Real-Time Price · USD
19.61
+0.11 (0.56%)
May 3, 2024, 4:00 PM EDT - Market closed

Organon & Co. Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
69370673712319
Cash & Cash Equivalents
69370673712319
Cash Growth
-1.84%-4.21%6041.67%-96.24%-
Receivables
1,7441,4751,3821,0381,487
Inventory
1,3151,0039159131,071
Other Current Assets
7567477261,6041,078
Total Current Assets
4,5083,9313,7603,5673,955
Property, Plant & Equipment
1,1831,018973984680
Goodwill and Intangibles
5,1365,2525,2545,1065,172
Other Long-Term Assets
1,231754694452741
Total Long-Term Assets
7,5507,0246,9216,5426,593
Total Assets
12,05810,95510,68110,10910,548
Accounts Payable
1,3141,1321,3821,598292
Current Debt
98900
Other Current Liabilities
1,5951,3721,2061,0751,049
Total Current Liabilities
2,9182,5122,5972,6731,341
Long-Term Debt
8,7518,9059,125070
Other Long-Term Liabilities
4594304671,9502,102
Total Long-Term Liabilities
9,2109,3359,5921,9502,172
Total Liabilities
12,12811,84712,1894,6233,513
Total Debt
8,7608,9139,134070
Debt Growth
-1.72%-2.42%---
Retained Earnings
443-331-9980-
Comprehensive Income
-541-564-513-622-914
Shareholders' Equity
-70-892-1,5085,4867,035
Net Cash / Debt
-8,067-8,207-8,39712249
Net Cash / Debt Growth
----95.18%-
Net Cash Per Share
-31.48-32.16-33.030.050.98
Working Capital
1,5901,4191,1638942,614
Book Value Per Share
-0.27-3.51-5.9521.6427.75
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).